Deneen Vojta, M.D., and Richard Smith, M.D., two of UnitedHealth Group’s leading chronic disease experts, will address the 25 th Anniversary Nobel Peace Prize Forum, March 8-10 at Augsburg College in Minneapolis.
Dr. Vojta, senior vice president of the UnitedHealth Center for Health Reform & Modernization and chief clinical officer of the Diabetes Prevention and Control Alliance, and Dr. Richard Smith, director of the UnitedHealth Chronic Disease Initiative, will participate in the forum’s first-ever “Science and Health Day” Saturday, March 9. Their presentation, “Diabesity: Disease Gone Global,” will consider the “diabesity” dilemma – the clinical and behavioral chain that leads from childhood obesity to prediabetes to type 2 diabetes – from a global perspective.
Diabetes is one of the greatest health and economic challenges of the 21 st century, with more than 350 million people worldwide living with the disease, a figure that is expected to rise to more than 550 million within 20 years, according to the International Diabetes Federation (IDF). Vojta and Smith will describe concepts for successful global strategies to address this most pressing public health and economic crisis, including community-based programs that have been clinically proven to help prevent or delay the onset of type 2 diabetes.
“It is a great honor to speak at this year’s 25 th Anniversary Nobel Peace Prize Forum,” said Vojta. “The timing of this conference is critical, since the world’s diabesity epidemic is evolving from a significant public health issue to one that, if gone unchecked, poses a true threat to global prosperity.”Smith said: “We are grateful for the opportunity to address the Nobel Peace Prize Forum and help draw attention to a true global pandemic. The prevalence of prediabetes and diabetes has increased dramatically over the past two decades on a parallel track with the global increase in obesity and unsustainable lifestyles.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts